Company intelligence / Profile preview

8VC

Austin, Texas, United States

Ownership: Private
Development stage: Other

Overview

8VC is a technology and life sciences-focused investment firm and company builder that invests in, and builds, a variety of healthcare, biotech, deeptech, and infrastructure startups. It is not a therapeutics development company itself but has co-founded and backed many in these sectors, including Resilience (CDMO), Appia Bio (cell therapy), Atomic AI (AI-driven drug discovery), BiomX (phage therapy), and Orca Bio (cell therapy). 8VC itself does not have a clinical pipeline, but its portfolio includes many companies at preclinical and clinical stages across multiple modalities.

Industry: Investors

Beyond the preview

Go deeper on 8VC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 8VC.

Explore the full profile